Skip to main content
Abrocitinib remains effective at 96 weeks, in older as well as younger adults
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Abrocitinib remains effective at 96 weeks, in older as well as younger adults
User login
Username
Password
Reset your password
Concept
Lead
score
Dermatitis
1
1
Young Adult
0
0.98
Atopic Dermatitis
0
0.99
Clinical Research
0
0.4
Pruritus
0
0.4
Healthcare and Medical Technology
0
0.32
Adolescent Medicine
0
0.97
Eczema
0
0.2
New York
0
0.2
Preventive Screening
0
0.2
Quality of Life
0
0.2
Severity Index
0
0.2
Specialty
Lead
score
Dermatology
1
1
Family Medicine/Primary Care
0
0.9
Internal Medicine
0
0.8
Edit Tags